Therefore, salivary biomarkers like the pro-inflammatory cytokines IL-1β, IL-2 and TNF might be used as a future diagnostic tool for oral squamous cell carcinoma [27]. This evidence concerns the gene IL2 and oral cavity squamous cell carcinoma.